Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 51,566 shares at $116.19 ($5.9M) on 2025-09-16, disclosed to the SEC on 2025-09-17.
Scheduled sale ($5.9M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.23 | 40,000 | $4.6M | 77.3% |
| 2 | $116.19 | 5,783 | $672K | 11.4% |
| 3 | $116.19 | 5,783 | $672K | 11.4% |
| Total | $114.67 avg | 51,566 | $5.9M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $5.7M | — | Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-06-10 | $2.8M | — | Filing → |